There is an urgent need to bring pharmaceutical and over-the-counter (OTC) drug manufacturing back to North America. CapsCanada launched this service to help address this issue.

According to the new market research report launched by Inkwood Research, The Global Antithrombotic Drugs market was valued at nearly $24900 million in 2017 and is anticipated to reach $45100 million by 2026, growing at an estimated CAGR of 6.83%, during the forecast period 2018-2026.